ONCO
Onconetix, Inc.1.9350
-0.0350-1.78%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
3.01MP/E (TTM)
0.00Basic EPS (TTM)
1229.73Dividend Yield
0%Recent Filings
8-K
8-K
8-K
8-K
Onconetix raises $6.25M via PIPE
On October 1, 2025, Onconetix secured $6.25 million through a PIPE financing, issuing 7,813 shares of Series E convertible preferred stock—each with a $1,000 stated value—and warrants for 2,025,223 common shares at $3.8576 per share. The preferred stock converts at $3.8576, with anti-dilution protections and a $0.7715 floor price, while warrants expire in three years and include cashless exercise options. This influx bolsters liquidity for general corporate needs, yet dilutes existing shareholders amid Nasdaq compliance hurdles. Deal closed swiftly.
8-K
Onconetix secures bridge notes
On August 28, 2025, Onconetix issued two $58,823.53 promissory notes to Keystone Capital Partners and its affiliate, each with $8,823.53 OID for $50,000 cash infusions, due upon ELOC proceeds or May 28, 2026, and subordinate to Veru debt. Veru amended its September note to $5.2 million principal at 10% interest, maturing September 19, 2025, while waiving April note payment to that date amid ongoing forbearance. These moves signal liquidity strain. Debt piles up.
AONC
American Oncology Network, Inc.
11.12+0.00
EPIX
ESSA Pharma Inc.
0.20+0.00
IMA
ImageneBio, Inc.
6.25+0.08
LH
Labcorp Holdings Inc.
258.11-5.22
OKUR
OnKure Therapeutics, Inc.
3.02-0.18
ONCY
Oncolytics Biotech Inc.
1.04+0.12
OTLC
Oncotelic Therapeutics, Inc.
0.09+0.00
PKTX
ProtoKinetix, Inc.
0.00+0.00
PTIX
Protagenic Therapeutics, Inc.
1.52-0.07
WHWK
Whitehawk Therapeutics, Inc.
2.40+0.04